Joint Formulary & PAD

Fluoxetine hydrochloride - Post-traumatic stress disorder (PTSD)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Capsules
Associated Icons :
Off Label
SPC
Restrictions / Comments :
 

Status 2

Blue
Formulations :
  • Dispersible tablets
  • Oral solution
Associated Icons :
Off Label
SPC
Restrictions / Comments :
Important

Fluoxetine dispersible tablets are the more cost effective option in patents without dysphagia.

Fluoxetine oral solution and dispersible tablets are clinically interchangable for oral use.

 

Status 3

Non Formulary
Formulations :
  • Tablets
Associated Icons :
NFD1
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Fluoxetine hydrochloride
Indication :
Post-traumatic stress disorder (PTSD)
Group Name :
Keywords :
SSRIs, selective serotonin re-uptake inhibitors, antidepressants
Brand Names Include :
Prozac
Important Information :

Off-label use. Initiation and stabilisation by the Mental Health specialist team for a minimum of 3 months before any transfer of prescribing.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
3

Committee Recommendations (0)

  • No records returned.

Other Indications

Below are listed other indications that Fluoxetine hydrochloride is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Post-traumatic stress disorder (PTSD).